| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 01/17/2008 | US20080015184 Urea Substituted Imidazopyridines, Imidazoquinolines, and Imidazonaphthyridines |
| 01/17/2008 | US20080015183 Substituted quinazolin-4-ylamine analogues |
| 01/17/2008 | US20080015178 Benzimidazoles, process for their preparation and use thereof as medicament |
| 01/17/2008 | US20080015146 e.g. 3-Amino-1-[(S)-2-(3-tert-butyl-[1,2,4]oxadiazol-5-yl)-pyrrolidin-1-yl]-4-(2,4,5-trifluorophenyl)-butan-1-one; dipeptidyl-peptidase inhibitor; antidiabetic, hypoglycemic agent; metabolic disorders, obesity, non-insulin dependent diabetes |
| 01/17/2008 | US20080014189 Diaminotriazoles useful as inhibitors of protein kinases |
| 01/17/2008 | DE102006032824A1 Substituierte Indazole Substituted indazoles |
| 01/17/2008 | DE102006031224A1 New sulfoximine-substituted pyrimidines useful for treating e.g. diseases caused by inflammatory, allergic or proliferative processes, oncological diseases, cancer, eye, autoimmune and neurodegerative diseases |
| 01/17/2008 | CA2658146A1 Crystalline nemorubicin hydrochloride |
| 01/17/2008 | CA2657902A1 Xinafoate salt of a substituted 5-oxazol-2-yl-quinoline compound |
| 01/17/2008 | CA2657601A1 Substituted indazoles |
| 01/17/2008 | CA2657552A1 Substituted diazepan orexin receptor antagonists |
| 01/17/2008 | CA2657336A1 Substituted isoxalines, pharmaceutical compositions containing same, methods of preparing same, and uses of same |
| 01/17/2008 | CA2657227A1 Pyrimidine derivatives as alk-5 inhibitors |
| 01/17/2008 | CA2657151A1 Isoindoline derivatives for the treatment of arrhythmias |
| 01/17/2008 | CA2657062A1 Substituted sulphoximines as tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 01/16/2008 | EP1878733A1 Pyrimidine derivatives as ALK-5 inhibitors |
| 01/16/2008 | EP1878730A1 Substituted isoxazolines, pharmaceutical compositions containing the same, methods of preparing the same, and uses of the same |
| 01/16/2008 | EP1878728A2 Derivatives of piperazine and higher homologues thereof for the treatment of inflammation-related disorders |
| 01/16/2008 | EP1878726A1 Substituted sulphoximines as Tie2 inhibitors and salts thereof, pharmaceutical compositions comprising the same, methods of preparing the same and uses of the same |
| 01/16/2008 | EP1878723A1 N-[(1,5-diphenyl-1H-pyrazol-3-yl)methyl]sulfonamide derivatives antagonists of the CB1 cannabinoids receptors |
| 01/16/2008 | EP1877405A1 Benzisoxazole piperidine compounds and methods of use thereof |
| 01/16/2008 | EP1877404A2 Novel cyclic amines |
| 01/16/2008 | EP1877399A1 Triazole derivatives as vasopressin antagonists |
| 01/16/2008 | EP1877383A1 Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity |
| 01/16/2008 | EP1877376A1 Novel compounds for treating inflammatory diseases |
| 01/16/2008 | EP1713778B1 Benzazepine derivatives as histamine h3 antagonists |
| 01/16/2008 | EP1567486B1 Bis-aryl sulfonamides |
| 01/16/2008 | EP1562918B1 Substituted benzoxazinones and uses thereof |
| 01/16/2008 | EP1501809B1 Triazole derivatives as tachykinin receptor antagonists |
| 01/16/2008 | EP1451154B1 Inhibitors of cytosolic phospholipase a2 |
| 01/16/2008 | EP1392306B1 Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases |
| 01/16/2008 | EP1122242B1 Cyanophenyl derivatives |
| 01/16/2008 | CN101107251A Bicyclic pyrimidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
| 01/16/2008 | CN101107245A Heteroaryl substituted piperazinyl-pyridine analogues |
| 01/16/2008 | CN101106998A Mitotic kinesin inhibitors |
| 01/16/2008 | CN101106991A 抗糖尿病的双环化合物 Bicyclic compounds antidiabetic |
| 01/16/2008 | CN101104598A Process for preparing trans-4-amino-1-cyclohexanecarboxilic acid derivatives |
| 01/16/2008 | CN100361990C Second order non-linear optical chromophore containing indolyl radical and its prepn and application |
| 01/16/2008 | CN100361982C Isoxazoline derivative and herbicide comprising the same as active ingredient |
| 01/15/2008 | US7319109 4-(Substituted phenoxy or anilino)-3-phenyl- or phenylalkylisoxazoles: 3-{[(4-{[3-(2,6-Dichlorophenyl)-5-isopropylisoxazol-4-yl]methoxy}-2-methylphenyl)-(methyl)amino]methyl}benzoic acid; cardiovascular disease, cholestatic liver disease, organ fibrosis, triglycerides, increasing high density lipoprotein |
| 01/15/2008 | US7319104 hPPARs activators |
| 01/15/2008 | US7319100 1-(1H-Pyrazin-2-on-3-yl)tetrahydroquinolines (3-(8-Bromo-6-methoxy-1,2,3,4-tetrahydroquinoline)-5-chloro-1-(1-ethylpropyl)-2(1H)-pyrazinone); treating anxiety and depression |
| 01/15/2008 | US7319098 1,3-dioxoisoindole derivatives having selective antagonism of T-type calcium channel |
| 01/15/2008 | US7319097 Treatment of type II diabetes with benzenesulfonamide substituted with an N-heterocycle: N-[2-amino-5-(1,4-diazepan-1-yl)phenyl]benzenesulfonamide, N-[4-amino-5-(piperazinyl)phenyl]benzenesulfonamide, 3-amino-4-(5-methyl-2,5-diaza-bicyclo[2.2.1]hept-2-yl)-N-phenyl-benzenesulfonamide hydrochloride |
| 01/15/2008 | US7318966 Luminescent element material and luminescent element comprising the same |
| 01/15/2008 | US7318823 Methods for repairing damaged intervertebral discs |
| 01/15/2008 | CA2536914C Crystal forms of azithromycin |
| 01/15/2008 | CA2218479C 1,4-di-substituted piperidine derivatives |
| 01/10/2008 | WO2008005908A2 Pyridoimidazole derivatives |
| 01/10/2008 | WO2008005338A1 Modulators of the histamine h3-receptor useful for the treatment of disorders related thereto |
| 01/10/2008 | WO2008004946A1 New pyridine analogues |
| 01/10/2008 | WO2008004943A1 New pyridine analogues |
| 01/10/2008 | WO2008004942A1 New pyridine analogues |
| 01/10/2008 | WO2008004941A1 New pyridine analogues |
| 01/10/2008 | WO2008004096A1 Pyrazole derivatives as cytochrome p450 inhibitors |
| 01/10/2008 | WO2008003861A1 Compounds having a potentiating effect on the activity of ethionamide and uses thereof |
| 01/10/2008 | WO2008003857A1 Pyrazolylbenzimidazole derivatives, compositions containing them and use thereof |
| 01/10/2008 | WO2008003770A1 Phenyl substituted heteroaryl-derivatives and use thereof as anti-tumor agents |
| 01/10/2008 | WO2008003665A1 Benzimidazole cannabinoid agonists bearing a substituted heterocyclic group |
| 01/10/2008 | WO2008003607A1 Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and agents containing said compounds |
| 01/10/2008 | WO2007136680A3 3-pyraz0lyl-benzamide-4-ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 01/10/2008 | WO2007136572A3 Antidiabetic bicyclic compounds |
| 01/10/2008 | WO2007131764A3 New heterocyclic compounds for the inhibition of integrins and use thereof |
| 01/10/2008 | WO2007123853A3 Five-membered heterocyclic invertebrate pest control agents |
| 01/10/2008 | WO2007116313A3 Pyrrolidine derivatives as modulators of chemokine ccr5 receptors |
| 01/10/2008 | WO2007109334A3 Sip receptor modulating compounds and use thereof |
| 01/10/2008 | WO2007093292A3 Insecticidal substituted amino heterocyclic and heteroaryl derivatives |
| 01/10/2008 | US20080009631 e.g. 2-[4-[3-[2-(2,4-Dichlorophenyl)-5-isopropyl-4-oxazolyl]propionyl]-2-methylphenoxy]-2-methylpropionic acid; |
| 01/10/2008 | US20080009531 5-Anilino-4-Heteroarylpyrazole Derivatives Useful for the Treatment of Diabetes |
| 01/10/2008 | US20080009525 Activator of peroxisome proliferator-activated receptor delta |
| 01/10/2008 | US20080009520 Benzimidazolidinone derivatives as muscarinic agents |
| 01/10/2008 | US20080009506 Imidazole Compound |
| 01/10/2008 | US20080009494 Cycloalkyl Substituted Pyrimidinediamine Compounds And Their Uses |
| 01/10/2008 | US20080009493 Substituted Benzimidazoles and Imidazo-[4,5]-Pyridines |
| 01/10/2008 | US20080009492 (2-Phenyl-1H-pyrrolo[2,3-b]pyridin-5-yl)-carbamic acid isopropyl ester, used in the control or prevention of illnesses such as cancer; anticarcinogenic agents |
| 01/10/2008 | US20080009491 1-(3-naphthalen-1-yl-imidazo[1,5-a]pyridin-1-yl)-butan-1-one; chronic pain, an inflammatory disorder, rheumatoid arthritis, multiple sclerosis, osteoporosis and osteoarthritis; cannabinoid receptor ligands |
| 01/10/2008 | US20080009490 pyrazino[1,2-c]pyrimidine derivatives; viricide; infection by HIV, AIDS; with other HIV/AIDS antivirals, immunomodulators, antibiotics or vaccines; 2-(4-Fluorobenzyl)-9-hydroxy-7-[(1R,2S)-2-phenylcyclopropyl]-3,4-dihydro-2H-pyrazino[1,2-c]pyrimidine-1,6,8(7H)-trione |
| 01/10/2008 | US20080009488 protein kinase inhibitors such as Methyl {5-[2-(5-chloro-2-methylphenyl)-1-hydroxy-3-oxo-2,3-dihydro-1H-isoindol-1-yl]-1H-benzimidazol-2-yl}carbamate, used to modulate cellular activities such as proliferation, differentiation, apoptosis, migration and chemoinvasion |
| 01/10/2008 | US20080009479 Tetrahydrobenzazepines as Histamine H3 Receptor Ligands |
| 01/10/2008 | US20080008655 Cyanine dye bioconjugates useful for diagnostic imaging and therapy; for photoacoustic imaging and detection of tumors; do not aggregate in solution, form starburst dendrimers, are capable of absorbing or omitting light in the near infrared region; Bis(ethylcarboxymethyl)indocyanine Dye |
| 01/10/2008 | CA2660031A1 Pyrazole derivatives as cytochrome p450 inhibitors |
| 01/10/2008 | CA2656597A1 New pyridine analogues |
| 01/10/2008 | CA2656502A1 Compounds having a potentiating effect on the activity of ethionamide and uses thereof |
| 01/10/2008 | CA2655633A1 New pyridine analogues |
| 01/10/2008 | CA2655629A1 New pyridine analogues |
| 01/10/2008 | CA2655628A1 New pyridine analogues |
| 01/10/2008 | CA2654246A1 Benzimidazole cannabinoid agonists bearing a substituted heterocyclic group |
| 01/09/2008 | EP1876174A1 Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors |
| 01/09/2008 | EP1874776A1 Oxazole and thiazole compounds and their use in the treatment of pge2 mediated disorders |
| 01/09/2008 | EP1874765A2 Urea derivatives methods for their manufacture and uses thereof |
| 01/09/2008 | EP1874764A2 Imino-oxazolidines and use thereof as anticoagulants |
| 01/09/2008 | EP1874763A2 Polymorph form ii of tanaproget |
| 01/09/2008 | EP1874749A1 FURAN COMPOUNDS USEFUL AS EPl RECEPTOR ANTAGONISTS |
| 01/09/2008 | EP1874743A2 Purified form of tanaproget |
| 01/09/2008 | EP1874742A1 3,4-dihydro-benzo[e][1,3]oxazin-2-ones |
| 01/09/2008 | EP1874741A1 Azole derivatives in the form of lipase and phospholipase inhibitors |
| 01/09/2008 | EP1874303A1 Pyrazole compounds as prostaglandin receptors ligands |
| 01/09/2008 | EP1527048B1 N-[phenyl(piperidin-2-yl)methyl]benzamide derivatives, preparation thereof, and use thereof in therapy |
| 01/09/2008 | EP1487809B1 Process for the preparation of morpholine derivatives and intermediates therefore |
| 01/09/2008 | EP1385845B1 N-aroyl cyclic amines |